Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Policy & Legislation

$783.5M in Covid Relief Money Went to Prisoners

Posted on June 10, 2022 by John C. Goodman

Passed in March, the American Rescue Plan granted $1,400 in stimulus money to people making less than $75,000 per year. Republicans objected to sending these checks to incarcerated individuals, but lost on a party line vote. According to  a Fox News report:

In response to a public records request from conservative group American Crossroads, the Internal Revenue Service (IRS) revealed that the money flowed to 560,000 individuals who were incarcerated for the full tax year 2020.

Among the recipients of Covid money was the Boston Marathon Bomber.

+

Friday Links

Posted on June 10, 2022July 25, 2022 by John C. Goodman
  • 80 experts object to a proposal to slap a 95% tax on drugs that do not submit to price controls.
  • China has matched the United States in output in seven high-tech sectors, including pharmaceuticals and medical products. 
  • If worry about climate change is a mental health issue, why is the W.H.O. contributing to the problem?
  • The good news on immigration.
+

The FTC wants to Know if Middlemen Increase Drug Prices

Posted on June 8, 2022June 8, 2022 by Devon Herrick

The Federal Trade Commission (FTC) is opening an investigation into the business practices of pharmacy benefit managers (PBMs). PBMs have been in the hotseat for quite some time. Executives from the largest PBMs were recently called to testify before Congress to explain whether their business practices lead to higher drug prices. In the latest inquiry, the FTC announced it will require the six largest PBMs to provide a range of information and business records on operations.

+

Who Does the AARP Represent?

Posted on June 6, 2022 by Devon Herrick

The AARP, the legendary advocacy for seniors aged 50 and above, has come under increased scrutiny in recent years for its marketing partnerships. Much of AARP’s revenue comes from licensing its name and logo to sell a wide range of goods and services targeted to seniors. The AARP is undoubtedly a senior advocacy, but it is also a marketing juggernaut that sells insurance.

+
  • Previous
  • 1
  • …
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • …
  • 272
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom